Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Labcorp Holdings Inc.

Market Cap 22.24B 19.24B 17.73B 16.61B 31.03B 2,121B 31.6B 210B 81.6B 1,026B 83.52B 81.7B 3,565B P/E ratio 2026 *
19.5x
P/E ratio 2027 * 17.5x
Enterprise value 26.87B 23.25B 21.42B 20.08B 37.5B 2,563B 38.18B 254B 98.6B 1,239B 101B 98.72B 4,307B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.7x
Free-Float
99.64%
Yield 2026 *
1.07%
Yield 2027 * 1.08%
1 day+3.52%
1 week+5.25%
Current month+4.30%
1 month+6.74%
3 months-0.87%
6 months+5.11%
Current year+8.12%
1 week 259.99
Extreme 259.99
271.33
1 month 250
Extreme 250
271.33
Current year 245
Extreme 245
292.02
1 year 241.81
Extreme 241.81
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
11/05Sell

Chief Executive Officer

-5,903 0.0072%
26/03Free

EVP, Operations

3,938 0.0048%
26/03Free

Chief Executive Officer

84,576 0.1026%
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+5.25%+6.06%+24.67% 21.48B
+4.38%+4.74%+35.71%+360.56% 30.57B
+1.01%+6.20%-25.09%-43.33% 6.76B
+3.73%+3.44%-4.89%+75.02% 4.26B
+1.93%+0.95%+9.63%+61.15% 2.71B
+5.08%-4.43%-19.69%-66.39% 1.6B
+3.47%-0.78%+17.27%+0.51% 1.55B
+8.75%+6.02%-22.22%+792.71% 1.54B
+2.52%-5.72%+8.82%-34.82% 1.47B
+4.47%+13.04%+51.32%-30.50% 1.43B
Average +3.89%+1.58%+5.69%+113.96% 7.34B
Weighted average by Cap. +3.74%+3.65%+15.06%+174.00%

Financials

2026 *2027 *
Net sales 14.71B 12.72B 11.72B 10.99B 20.52B 1,403B 20.9B 139B 53.96B 678B 55.23B 54.03B 2,357B 15.42B 13.34B 12.29B 11.52B 21.51B 1,470B 21.91B 146B 56.57B 711B 57.9B 56.64B 2,471B
Net income 1.13B 977M 900M 844M 1.58B 108B 1.6B 10.68B 4.14B 52.08B 4.24B 4.15B 181B 1.24B 1.07B 985M 923M 1.72B 118B 1.76B 11.68B 4.53B 56.99B 4.64B 4.54B 198B
Net Debt 4.63B 4.01B 3.69B 3.46B 6.46B 442B 6.58B 43.81B 17B 214B 17.4B 17.02B 743B 3.94B 3.41B 3.14B 2.94B 5.5B 376B 5.6B 37.26B 14.46B 182B 14.8B 14.48B 632B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
09/06/26 271.24 $ +3.52% 602,379
08/06/26 262.01 $ -1.18% 507,006
05/06/26 265.15 $ +1.60% 429,298
04/06/26 260.97 $ +0.79% 519,699
03/06/26 258.92 $ +0.47% 679,789
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
271.24USD
Average target price
310.12USD
Spread / Average Target
+14.33%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW